ALK-Abelló A/S (OTCMKTS:AKBLF – Get Free Report) rose 8.3% during mid-day trading on Wednesday. The company traded as high as $36.50 and last traded at $36.50. Approximately 1,197 shares traded hands during trading, an increase of 127% from the average session volume of 528 shares. The stock had previously closed at $33.70.
ALK-Abelló A/S Stock Performance
The firm’s 50-day moving average price is $34.49 and its 200 day moving average price is $36.20.
About ALK-Abelló A/S
ALK-Abelló A/S is a Denmark-based pharmaceutical company focused on the research, development, manufacturing and commercialization of allergy immunotherapy products. The company’s treatments are designed to address the underlying causes of allergies by gradually increasing a patient’s tolerance to specific allergens, rather than treating symptoms alone.
Its portfolio includes sublingual allergy immunotherapy tablets and other products for conditions such as grass pollen, tree pollen, ragweed pollen and house dust mite allergies.
Featured Articles
- Five stocks we like better than ALK-Abelló A/S
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
